Skip to search boxSkip to navigationSkip to main content

Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites

  • D. V. Vlahakos
    ,
  • M. H. Foster
    ,
  • S. Adams
    ,
  • M. Katz
    ,
  • A. A. Ucci
    ,
  • K. J. Barrett
*Corresponding author for this work
  • University of Pennsylvania
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

To investigate the capacity of lupus autoAb to produce glomerular immune deposits (ID) and nephritis, 24 murine monoclonal (m) anti-DNA antibodies (Ab), derived from either MRL-lpr/lpr, SNF1 or NZB lupus-prone mice and selected based on properties shared with nephritogenic Ig, were administered i.p. (as hybridomas) and i.v. (as purified Ig) to normal mice; at least four mice/mAb were evaluated. Three general patterns of immune deposit formation (IDF) were observed: extracellular 1D within glomeruli (± blood vessels. N = 8); intranuclear ID (N = 5); or minimal or no ID (A = 11). The four MRL m anti-DNA Ab that produced significant extracellular ID demonstrated different disease profiles including: (a) mesangial and subendothelial ID with anti-basement membrane staining, associated with proliferative glomerulonephritis, PMN infiltration, and proteinuria: (b) diffuse fine granular mesangial and extraglomerular vascular ID, associated with proliferative glomerulonephritis and proteinuria: (c) dense intramembranous ID and intraluminal ID, associated with capillary wall thickening, mesangial interposition and expansion, aneurysmal dilatation and intraluminal occlusion of glomerular capillary loops, and heavy proteinuria; and (d) mesangial and extraglomerular vascular ID, associated with mild segmental mesangial expansion, without proteinuria. These MRL mAb were derived from four different mice, and they had variable pIs and isotypes. They all cross reacted with multiple autoantigens (autoAg), however, their autoAg binding profiles were distinguishable. Among the SNF1 derived mAb, four produced histologically and clinically indistinguishable disease characterized by diffuse mesangial and capillary wall ID, associated with cellular proliferation/infiltration and proteinuria. Three of the four mAb were derived from the same mouse and were clonally related; they were: IgG2b with SWR allotype, relatively cationic, highly cross reactive with similar Ag binding patterns, idiotypically related and encoded by identical V(H) and nearly identical V(L) sequences. We conclude that both the capacity of lupus autoAb to form ID and the location of IDF are dependent on properties unique to individual Ig. The results also indicate that the Ag binding region of the autoAb is influential in this process, and they suggest that multiple Ab-Ag interactions contribute to IDF in individuals with lupus nephritis. Furthermore, these observations raise the possibility that the pathologic and clinical abnormalities resulting from these interactions are influenced by the location of IDE, and that the dominant interaction, in a given individual, may be highly influential in the phenotypic expression of nephritis.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1690-1700 (11 pages)

Journal (Volume, Issue Number)

Kidney International (Volume 41, Issue 6)

Publication milestones

  • Published - 1992

Publication status

Published - 1992

ISSN

0085-2538

Publication IDs

  • Scopus: 0026753816
  • PubMed: 1501424

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.13
Fractional count
7
Fractional count
0.88
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
222
Captures
30

Funding Details

37:435, 1990). This work was supported in part by the following: United States Public Health Service Awards: DK33694 and AM36541(MPM), DK01904(MHF), CA31789(SKD), and AR38821(KJB). Dr. Foster was the recipient of fellowships from the National Kidney Foundation, American Society of Nephrology and AMGEN. The authors thank Kenneth Baur and Margarett MacDonald for technical support.
FundersFunding numbers
NIDDK
R01DK033694
USPHS
AM36541, AR38821, DK01904, CA31789